220
Participants
Start Date
October 12, 2022
Primary Completion Date
November 22, 2022
Study Completion Date
January 3, 2023
Ranquilon
Two 1 mg tablets 3 times per day for 28 days
Placebo
Two tablets 3 times per day for 28 days
"Limited Liability Company Research Center Eco-Security", Saint Petersburg
EosMED JSC, Saint Petersburg
"Limited Liability Company Energy of Health", Saint Petersburg
"LLC Aurora MedFort", Saint Petersburg
"Limited Liability Company Research Center Eco-Safety", Saint Petersburg
"Limited Liability Company Meili", Saint Petersburg
Saratov City Psychoneurological Dispensary, Saratov
Engels Psychiatric Hospital State Health Care Institution of the Ministry of Health of the Saratov Region, Engel's
"State Budgetary Health Institution of Nizhny Novgorod Oblast Clinical Psychiatric Hospital No. 1 of Nizhny Novgorod. Nizhny Novgorod", Nizhny Novgorod
Professors' Clinic LLC., Perm
Valenta Pharm JSC
INDUSTRY